Fludarabine
Recurrent Adult Hodgkin Lymphoma
M.D. Anderson Cancer CenterSmall moleculePhase 3Active
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 62/ 100
- Competitive Position
- 95/ 100
Competitive context
149 Active assets in the Recurrent Adult Hodgkin Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CYCLOSPORIN A City of Hope Medical Center | Phase 3 | BBB |
FILGRASTIM Fred Hutchinson Cancer Center | Phase 3 | BBB |
METHOTREXATE Therapeutic Advances in Childhood Leukemia Consortium | Phase 3 | BBB |
Cytosin-Arabinosid Therapeutic Advances in Childhood Leukemia Consortium | Phase 3 | BBB |
Everolimus OHSU Knight Cancer Institute | Phase 2 | BBB |
View all 50 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →